ENANTA PHARMACEUTICALS INC（ENTA）内部人交易：高管与董事近期交易
过去 18 个月，共有 8 位内部人为 ENANTA PHARMACEUTICALS INC（ENTA）报告了 37 笔 Form 4 交易（最近一笔 2026-08-10）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-10 | Rottinghaus Scott T. | Chief Medical Officer | 卖出 | 1,467 | $19,570 |
| 2026-02-13 | Kieffer Tara Lynn | Chief Product Strategy Officer | 卖出 | 3,257 | $46,412 |
| 2026-02-13 | Rottinghaus Scott T. | Chief Medical Officer | 买入 | 5,225 | $0 |
| 2026-02-13 | Rottinghaus Scott T. | Chief Medical Officer | 卖出 | 3,413 | $48,635 |
| 2026-02-13 | Or Yat Sun | Chief Scientific Officer | 买入 | 1,650 | $0 |
| 2026-02-13 | Or Yat Sun | Chief Scientific Officer | 买入 | 5,225 | $0 |
| 2026-02-13 | Or Yat Sun | Chief Scientific Officer | 卖出 | 3,413 | $48,635 |
| 2026-02-13 | Luly Jay R. | President and CEO | 买入 | 4,800 | $0 |
| 2026-02-13 | Luly Jay R. | President and CEO | 买入 | 15,200 | $0 |
| 2026-02-13 | Luly Jay R. | President and CEO | 卖出 | 6,155 | $87,709 |
| 2026-02-13 | Kieffer Tara Lynn | Chief Product Strategy Officer | 买入 | 1,575 | $0 |
| 2026-02-13 | Kieffer Tara Lynn | Chief Product Strategy Officer | 买入 | 4,987 | $0 |
| 2026-02-13 | Rottinghaus Scott T. | Chief Medical Officer | 买入 | 1,650 | $0 |
| 2026-02-13 | Kowalsky Matthew Paul | Chief Legal Officer | 买入 | 1,318 | $0 |
| 2026-02-13 | Kowalsky Matthew Paul | Chief Legal Officer | 买入 | 4,175 | $0 |
| 2026-02-13 | Kowalsky Matthew Paul | Chief Legal Officer | 卖出 | 1,902 | $27,104 |
| 2026-02-13 | Luu Brendan | Chief Business Officer | 买入 | 1,575 | $0 |
| 2026-02-13 | Luu Brendan | Chief Business Officer | 买入 | 4,987 | $0 |
| 2026-02-13 | Luu Brendan | Chief Business Officer | 卖出 | 3,257 | $46,412 |
| 2025-12-05 | Or Yat Sun | Chief Scientific Officer | 卖出 | 2,390 | $34,010 |
| 2025-12-05 | Capps Kathleen S. | Executive Director of Accounting, Controller (Principal Accounting Officer) | 卖出 | 323 | $4,596 |
| 2025-12-05 | Trout Harry R. III | Vice President, Finance (Principal Financial Officer) | 卖出 | 542 | $7,713 |
| 2025-12-05 | Kieffer Tara Lynn | Chief Product Strategy Officer | 卖出 | 2,106 | $29,968 |
| 2025-12-05 | Luu Brendan | Chief Business Officer | 卖出 | 1,394 | $19,837 |
| 2025-12-05 | Luly Jay R. | President and CEO | 卖出 | 4,743 | $67,493 |
来源：SEC Form 4 申报文件 · 截至 2026-08-10